BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12562661)

  • 1. Cancer prevalence in Central Europe: the EUROPREVAL Study.
    Lutz JM; Francisci S; Mugno E; Usel M; Pompe-Kirn V; Coebergh JW; Bieslka-Lasota M;
    Ann Oncol; 2003 Feb; 14(2):313-22. PubMed ID: 12562661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer prevalence in European registry areas.
    Micheli A; Mugno E; Krogh V; Quinn MJ; Coleman M; Hakulinen T; Gatta G; Berrino F; Capocaccia R;
    Ann Oncol; 2002 Jun; 13(6):840-65. PubMed ID: 12123330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer prevalence in the UK: results from the EUROPREVAL study.
    Forman D; Stockton D; Møller H; Quinn M; Babb P; De Angelis R; Micheli A
    Ann Oncol; 2003 Apr; 14(4):648-54. PubMed ID: 12649115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
    AIRTUM Working Group
    Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of cancer incidence and mortality in Europe in 1995.
    Bray F; Sankila R; Ferlay J; Parkin DM
    Eur J Cancer; 2002 Jan; 38(1):99-166. PubMed ID: 11750846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
    AIRTUM Working Group
    Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.
    Black RJ; Bray F; Ferlay J; Parkin DM
    Eur J Cancer; 1997 Jun; 33(7):1075-107. PubMed ID: 9376190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
    Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
    Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer prevalence in Northern Europe: the EUROPREVAL study.
    Möller T; Anderson H; Aareleid T; Hakulinen T; Storm H; Tryggvadottir L; Corazziari I; Mugno E;
    Ann Oncol; 2003 Jun; 14(6):946-57. PubMed ID: 12796034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of rare cancers and inequalities in oncologic outcomes.
    Gatta G; Trama A; Capocaccia R;
    Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.
    Chirlaque MD; Salmerón D; Galceran J; Ameijide A; Mateos A; Torrella A; Jiménez R; Larrañaga N; Marcos-Gragera R; Ardanaz E; Sant M; Minicozzi P; Navarro C; Sánchez MJ;
    Clin Transl Oncol; 2018 Feb; 20(2):201-211. PubMed ID: 28718071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
    Allemani C; Weir HK; Carreira H; Harewood R; Spika D; Wang XS; Bannon F; Ahn JV; Johnson CJ; Bonaventure A; Marcos-Gragera R; Stiller C; Azevedo e Silva G; Chen WQ; Ogunbiyi OJ; Rachet B; Soeberg MJ; You H; Matsuda T; Bielska-Lasota M; Storm H; Tucker TC; Coleman MP;
    Lancet; 2015 Mar; 385(9972):977-1010. PubMed ID: 25467588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
    Minicozzi P; Walsh PM; Sánchez MJ; Trama A; Innos K; Marcos-Gragera R; Dimitrova N; Botta L; Johannesen TB; Rossi S; Sant M;
    Eur J Cancer; 2018 Apr; 93():127-137. PubMed ID: 29518726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group.
    Vercelli M; Capocaccia R; Quaglia A; Casella C; Puppo A; Coebergh JW
    Crit Rev Oncol Hematol; 2000 Sep; 35(3):161-79. PubMed ID: 10960799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20-49 Years.
    Ward EM; Sherman RL; Henley SJ; Jemal A; Siegel DA; Feuer EJ; Firth AU; Kohler BA; Scott S; Ma J; Anderson RN; Benard V; Cronin KA
    J Natl Cancer Inst; 2019 Dec; 111(12):1279-1297. PubMed ID: 31145458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer prevalence estimates in Europe at the beginning of 2000.
    Gatta G; Mallone S; van der Zwan JM; Trama A; Siesling S; Capocaccia R;
    Ann Oncol; 2013 Jun; 24(6):1660-6. PubMed ID: 23553062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group.
    Quinn MJ; Martinez-Garcia C; Berrino F
    Eur J Cancer; 1998 Dec; 34(14 Spec No):2204-11. PubMed ID: 10070288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.